Treatment of Helicobacter pylori infection: a review.
Blecker
U
U
Division of Pediatric Gastroenterology, Louisiana State University Medical Center, New Orleans 70112, USA. ublecker@mail.peds.lsumc.edu
Gold
B D
BD
D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D000897:Anti-Ulcer Agents / Q000627:therapeutic use*; D001729:Bismuth / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D004359:Drug Therapy, Combination; D016481:Helicobacter Infections / Q000188:drug therapy* / Q000276:immunology / Q000517:prevention & control; D016480:Helicobacter pylori; D006635:Histamine H2 Antagonists / Q000627:therapeutic use*; D006801:Humans; D007223:Infant; D010349:Patient Compliance; D014612:Vaccines / Q000276:immunology
D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D006635:Histamine H2 Antagonists; D014612:Vaccines; D001729:Bismuth